Toronto Dominion Bank Increases Stock Holdings in Humana Inc. (NYSE:HUM)

Toronto Dominion Bank boosted its stake in Humana Inc. (NYSE:HUM - Free Report) by 7.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 64,447 shares of the insurance provider's stock after acquiring an additional 4,455 shares during the quarter. Toronto Dominion Bank owned 0.05% of Humana worth $16,351,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Assenagon Asset Management S.A. lifted its stake in Humana by 21.5% in the 4th quarter. Assenagon Asset Management S.A. now owns 4,969 shares of the insurance provider's stock valued at $1,261,000 after buying an additional 879 shares in the last quarter. Merit Financial Group LLC increased its position in shares of Humana by 16.6% during the fourth quarter. Merit Financial Group LLC now owns 1,819 shares of the insurance provider's stock worth $461,000 after purchasing an additional 259 shares in the last quarter. Clarius Group LLC raised its stake in Humana by 7.0% in the 4th quarter. Clarius Group LLC now owns 905 shares of the insurance provider's stock valued at $230,000 after purchasing an additional 59 shares during the last quarter. Willner & Heller LLC lifted its holdings in Humana by 28.2% in the 4th quarter. Willner & Heller LLC now owns 2,002 shares of the insurance provider's stock valued at $508,000 after purchasing an additional 440 shares in the last quarter. Finally, Atwood & Palmer Inc. grew its holdings in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after buying an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on HUM shares. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Thursday, May 1st. Robert W. Baird raised their target price on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Barclays upped their price target on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research report on Friday, April 11th. JPMorgan Chase & Co. reduced their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 18th. Finally, Morgan Stanley dropped their target price on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average price target of $286.81.

Humana Stock Performance

Shares of Humana stock opened at $247.16 on Tuesday. The stock has a market capitalization of $29.83 billion, a price-to-earnings ratio of 24.84, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The business has a 50-day moving average of $262.90 and a 200 day moving average of $269.48. Humana Inc. has a 12 month low of $212.45 and a 12 month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm earned $7.23 EPS. As a group, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.43%. The ex-dividend date is Friday, June 27th. Humana's payout ratio is presently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.